228 related articles for article (PubMed ID: 32283193)
21. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J
J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476
[TBL] [Abstract][Full Text] [Related]
22. Aptamer-Mediated Polymeric Vehicles for Enhanced Cell-Targeted Drug Delivery.
Tan KX; Danquah MK; Sidhu A; Yon LS; Ongkudon CM
Curr Drug Targets; 2018 Feb; 19(3):248-258. PubMed ID: 27321771
[TBL] [Abstract][Full Text] [Related]
23. Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.
Zhu H; Li J; Zhang XB; Ye M; Tan W
ChemMedChem; 2015 Jan; 10(1):39-45. PubMed ID: 25277749
[TBL] [Abstract][Full Text] [Related]
24. Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy.
Wang AZ; Bagalkot V; Vasilliou CC; Gu F; Alexis F; Zhang L; Shaikh M; Yuet K; Cima MJ; Langer R; Kantoff PW; Bander NH; Jon S; Farokhzad OC
ChemMedChem; 2008 Sep; 3(9):1311-5. PubMed ID: 18613203
[No Abstract] [Full Text] [Related]
25. Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy.
Fu Z; Xiang J
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266216
[TBL] [Abstract][Full Text] [Related]
26. Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications.
Kalomiraki M; Thermos K; Chaniotakis NA
Int J Nanomedicine; 2016; 11():1-12. PubMed ID: 26730187
[TBL] [Abstract][Full Text] [Related]
27. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells.
Farokhzad OC; Jon S; Khademhosseini A; Tran TN; Lavan DA; Langer R
Cancer Res; 2004 Nov; 64(21):7668-72. PubMed ID: 15520166
[TBL] [Abstract][Full Text] [Related]
28. Polymeric Engineering of Aptamer-Drug Conjugates for Targeted Cancer Therapy.
Deng Z; Yang Q; Peng Y; He J; Xu S; Wang D; Peng T; Wang R; Wang XQ; Tan W
Bioconjug Chem; 2020 Jan; 31(1):37-42. PubMed ID: 31815437
[TBL] [Abstract][Full Text] [Related]
29. A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy.
Dong Y; Yu T; Ding L; Laurini E; Huang Y; Zhang M; Weng Y; Lin S; Chen P; Marson D; Jiang Y; Giorgio S; Pricl S; Liu X; Rocchi P; Peng L
J Am Chem Soc; 2018 Nov; 140(47):16264-16274. PubMed ID: 30346764
[TBL] [Abstract][Full Text] [Related]
30. Nanotechnology and aptamers: applications in drug delivery.
Levy-Nissenbaum E; Radovic-Moreno AF; Wang AZ; Langer R; Farokhzad OC
Trends Biotechnol; 2008 Aug; 26(8):442-9. PubMed ID: 18571753
[TBL] [Abstract][Full Text] [Related]
31. Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery.
Liao J; Liu B; Liu J; Zhang J; Chen K; Liu H
Expert Opin Drug Deliv; 2015 Mar; 12(3):493-506. PubMed ID: 25430795
[TBL] [Abstract][Full Text] [Related]
32. Dendrimers in anticancer drug delivery: mechanism of interaction of drug and dendrimers.
Singh J; Jain K; Mehra NK; Jain NK
Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1626-34. PubMed ID: 26747336
[TBL] [Abstract][Full Text] [Related]
33. Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy.
Li J; Liang H; Liu J; Wang Z
Int J Pharm; 2018 Jul; 546(1-2):215-225. PubMed ID: 29787895
[TBL] [Abstract][Full Text] [Related]
34. Robust aptamer-polydopamine-functionalized M-PLGA-TPGS nanoparticles for targeted delivery of docetaxel and enhanced cervical cancer therapy.
Xu G; Yu X; Zhang J; Sheng Y; Liu G; Tao W; Mei L
Int J Nanomedicine; 2016; 11():2953-65. PubMed ID: 27382282
[TBL] [Abstract][Full Text] [Related]
35. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.
Dhar S; Gu FX; Langer R; Farokhzad OC; Lippard SJ
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17356-61. PubMed ID: 18978032
[TBL] [Abstract][Full Text] [Related]
36. Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting.
Bugno J; Hsu HJ; Hong S
J Drug Target; 2015; 23(7-8):642-50. PubMed ID: 26453160
[TBL] [Abstract][Full Text] [Related]
37. Precise delivery of celastrol by PEGylated aptamer dendrimer nanoconjugates for enormous therapeutic effect via superior intratumor penetration over antibody counterparts.
Niu B; Wu Y; Zhou M; Lin R; Ge P; Chen X; Zhou H; Zhang X; Xie J
Cancer Lett; 2023 Nov; 579():216461. PubMed ID: 37898358
[TBL] [Abstract][Full Text] [Related]
38. Polymeric Dendrimers as Nanocarrier Vectors for Neurotheranostics.
Li H; Zha S; Li H; Liu H; Wong KL; All AH
Small; 2022 Nov; 18(45):e2203629. PubMed ID: 36084240
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic aptamers: developmental potential as anticancer drugs.
Lee JW; Kim HJ; Heo K
BMB Rep; 2015 Apr; 48(4):234-7. PubMed ID: 25560701
[TBL] [Abstract][Full Text] [Related]
40. Aptamer-incorporated hydrogels for visual detection, controlled drug release, and targeted cancer therapy.
Liu J; Liu H; Kang H; Donovan M; Zhu Z; Tan W
Anal Bioanal Chem; 2012 Jan; 402(1):187-94. PubMed ID: 22052153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
